Patients diagnosed with AD are currently treated with acetylcholinesterase inhibitors (donepezil, rivastigmine or galantamine), with memantine, an NMDA receptor antagonist, being an additional treatment option for more severely-affected AD patients. This evidence concerns the gene ACHE and Alzheimer disease.